1887

Abstract

Plants have been used as medicines for centuries to treat human diseases. Studies with plants are extremely important for the development of future drugs that can benefit the human population.

With the emergence of pathogens resistant to antimicrobial agents, there is an urgent need to direct research towards the discovery of new antimicrobials.

In this study, L. (Anacardiaceae) was evaluated for its antimicrobial activity, antioxidant activity and cytotoxicity.

Antimicrobial activity was evaluated by the MIC using the 96-well plate microdilution technique of ethanolic, hexanic and dicloromethanic extracts of dried leaves against bacteria, yeast and filamentous fungi. The antioxidant activity of extracts was evaluated by the 2,2-diphenyl-1-picrylhydrazine (DPPH) method. To evaluate the safety of extracts, a cytotoxicity study against HaCat, J774 and HepG2 cells was performed.

The extracts had no activity against the bacteria at the maximum concentration of 5.0 mg ml, but showed fungistatic action against species and dermatophytes. The ethanolic extract showed 88 % antioxidant activity and showed no significant cytotoxicity against the previously mentioned cells.

This study showed that the 100 % ethanolic (EtOH) extract was favourable for antifungal and antioxidant activities and did not present significant cytotoxicity against the three studied cell lines, indicating that leaves are promising for the development of new antimicrobials.

Funding
This study was supported by the:
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Award Finance Code 001)
    • Principle Award Recipient: ThaisEmboaba de Oliveira
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001575
2022-09-13
2024-03-28
Loading full text...

Full text loading...

References

  1. Cragg GM, Newman DJ. Natural products: a continuing source of novel drug leads. Biochim Biophys Acta 2013; 1830:3670–3695 [View Article] [PubMed]
    [Google Scholar]
  2. Agência Nacional de Vigilância Sanitária Formulário de fitoterápicos da Farmacopeia Brasileira Brasília: BRASIL; 2011
    [Google Scholar]
  3. Murray CJL et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022; 399:629–655 [View Article] [PubMed]
    [Google Scholar]
  4. Centers for Disease Control and Prevention US Department of Health and Human Services, Antibiotic resistance threats in the United States. Atlanta: CDC; 2019 https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf
  5. Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health 2015; 109:309–318 [View Article] [PubMed]
    [Google Scholar]
  6. WHO World Health Organization. Global Action Plan On Antimicrobial Resistance Geneva: World Health Organization; 2015
    [Google Scholar]
  7. WHO World Health Organization. Antimicrobial Resistance World Health Organization; 2021
    [Google Scholar]
  8. Centers for Disease Control and Prevention US Department of Health and Human Services. Antibiotic resistance threats in the United States. Atlanta: CDC; 2013 http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf
  9. Kupferschmidt K. Long-awaited report outlines how to fight antimicrobial resistance—and how to pay for it. Science; 2016 https://www.science.org/content/article/long-awaited-report-outlines-how-fight-antimicrobial-resistance-and-how-pay-it
  10. O’Neill J. Antimicrobial Resistance: Tackling A Crisis for the Health and Wealth of Nations London: Review on Antimicrobial Resistance; 2014
    [Google Scholar]
  11. O’Neill J. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations London: Review on Antimicrobial Resistance; 2016
    [Google Scholar]
  12. Laxminarayan R, Sridhar D, Blaser M, Wang M, Woolhouse M. Achieving global targets for antimicrobial resistance: the UN should promote targets, funding, and governance. Science 2016; 353:874–875
    [Google Scholar]
  13. Blair JMA, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJV. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol 2015; 13:42–51 [View Article] [PubMed]
    [Google Scholar]
  14. Pillar C, Sahm D. Resistance trends and susceptibility profiles in the US among prevalent clinical pathogens: lessons from surveillance. In Dougherty TJ, Pucci MJ. eds Antibiotic Discovery and Development vol 2 New York: Springer; 2012 pp 753–792
    [Google Scholar]
  15. Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P T 2015; 40:277–283 [PubMed]
    [Google Scholar]
  16. Bongomin F, Gago S, Oladele RO, Denning DW et al. Global and multi-national prevalence of fungal diseases-estimate precision. J Fungi 2017; 3:E57 [View Article]
    [Google Scholar]
  17. Kumar Nigam P. Antifungal drugs and resistance: current concepts. Our Dermatol Online 2015; 6:212–221 [View Article]
    [Google Scholar]
  18. Vallabhaneni S, Cleveland AA, Farley MM, Harrison LH, Schaffner W et al. Epidemiology and risk factors for echinocandin nonsusceptible Candida glabrata bloodstream infections: data from a large multisite population-based Candidemia Surveillance Program, 2008-2014. Open Forum Infect Dis 2015; 2:ofv163 [View Article] [PubMed]
    [Google Scholar]
  19. Verweij PE, Chowdhary A, Melchers WJG, Meis JF. Azole resistance in Aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles?. Clin Infect Dis 2016; 62:362–368 [View Article] [PubMed]
    [Google Scholar]
  20. Rivero-Menendez O, Alastruey-Izquierdo A, Mellado E, Cuenca-Estrella M. Triazole resistance in Aspergillus spp.: a worldwide problem?. J Fungi 2016; 2:E21 [View Article]
    [Google Scholar]
  21. Lackner M, Hagen F, Meis JF, Gerrits van den Ende AHG, Vu D et al. Susceptibility and diversity in the therapy-refractory genus scedosporium. Antimicrob Agents Chemother 2014; 58:5877–5885 [View Article] [PubMed]
    [Google Scholar]
  22. Walsh TJ, Groll A, Hiemenz J, Fleming R, Roilides E et al. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 2004; 10 Suppl 1:48–66 [View Article] [PubMed]
    [Google Scholar]
  23. Berkow EL, Lockhart SR. Fluconazole resistance in Candida species: a current perspective. Infect Drug Resist 2017; 10:237–245 [View Article] [PubMed]
    [Google Scholar]
  24. Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis 2017; 64:134–140 [View Article] [PubMed]
    [Google Scholar]
  25. Zida A, Bamba S, Yacouba A, Ouedraogo-Traore R, Guiguemdé RT. Anti-Candida albicans natural products, sources of new antifungal drugs: a review. J Mycol Med 2017; 27:1–19 [View Article]
    [Google Scholar]
  26. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D et al. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized DISK diffusion. J Clin Microbiol 2010; 48:1366–1377 [View Article]
    [Google Scholar]
  27. Pfaller MA, Messer SA, Moet GJ, Jones RN, Castanheira M. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009). Int J Antimicrob Agents 2011; 38:65–69 [View Article]
    [Google Scholar]
  28. Yapar N. Epidemiology and risk factors for invasive candidiasis. Ther Clin Risk Manag 2014; 10:95–105 [View Article] [PubMed]
    [Google Scholar]
  29. Perfect JR. Is there an emerging need for new antifungals?. Expert Opin Emerg Drugs 2016; 21:129–131 [View Article] [PubMed]
    [Google Scholar]
  30. Moloney MG. Natural products as a source for Novel antibiotics. Trends Pharmacol Sci 2016; 37:689–701 [View Article] [PubMed]
    [Google Scholar]
  31. Rossiter SE, Fletcher MH, Wuest WM. Natural products as platforms to overcome antibiotic resistance. Chem Rev 2017; 117:12415–12474 [View Article] [PubMed]
    [Google Scholar]
  32. Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod 2020; 83:770–803 [View Article] [PubMed]
    [Google Scholar]
  33. Barbieri R, Coppo E, Marchese A, Daglia M, Sobarzo-Sánchez E et al. Phytochemicals for human disease: an update on plant-derived compounds antibacterial activity. Microbiol Res 2017; 196:44–68 [View Article] [PubMed]
    [Google Scholar]
  34. Guimarães DO, Momesso L da S, Pupo MT. Antibióticos: importância terapêutica e perspectivas para a descoberta e desenvolvimento de novos agentes. Quím Nova 2010; 33:667–679 [View Article]
    [Google Scholar]
  35. Marisco G, Pungartnik C. Spondias purpurea L. (Anacardiaceae): traditional uses, chemical composition and biological activities. Scientia Amazonia 2015; 4:10–18
    [Google Scholar]
  36. Alencar LC, Chaves TP, Santos JD, Nóbrega FP, Araújo RM et al. Efeito modular do extrato de plantas medicinais do gênero Spondias sobre a resistência de cepas de Staphylococcus aureus, à Eritromicina. Rev Ciênc Farm Básica Apl 2015; 36:111–116
    [Google Scholar]
  37. Cáceres A, Fletes L, Aguilar L, Ramirez O, Figueroa L et al. Plants used in Guatemala for the treatment of gastrointestinal disorders. 3. Confirmation of activity against enterobacteria of 16 plants. J Ethnopharmacol 1993; 38:31–38 [View Article]
    [Google Scholar]
  38. Bautista-Baños S, Hernández-López M, Dı́az-Pérez JC, Cano-Ochoa CF. Evaluation of the fungicidal properties of plant extracts to reduce Rhizopus stolonifer of ‘ciruela’ fruit (Spondias purpurea L.) during storage. Postharvest Biol Tech 2000; 20:99–106 [View Article]
    [Google Scholar]
  39. Bautista-Baños S, Barrera-Necha LL, Bravo-Luna L, Bermúdez-Torres K. Antifungal activity of leaf and stem extracts from various plant species on the incidence of Colletotrichum gloeosporioides of papaya and mango fruit after storage. Rev Mex Fitopatol 2002; 20:8–12
    [Google Scholar]
  40. Gachet MS, Lecaro JS, Kaiser M, Brun R, Navarrete H et al. Assessment of anti-protozoal activity of plants traditionally used in Ecuador in the treatment of leishmaniasis. J Ethnopharmacol 2010; 128:184–197 [View Article]
    [Google Scholar]
  41. Dantas AM. Avaliação da Toxicidade e Atividade Antiulcerogênica das Folhas de Spondias purpurea L. [s.L.]. Universidade Estadual da Paraíba; 2012 p 22
  42. de Almeida CLF, napço SA, de Santana TI, Costa HBA, de Carvalho Júnior CHR et al. Spondias purpurea L. (Anacardiaceae): antioxidant and antiulcer activities of the leaf hexane extract. Oxid Med Cell Longev 2017; 2017:6593073 [View Article]
    [Google Scholar]
  43. Almeida MMB, de Sousa PHM, Arriaga ÂMC, do Prado GM, Magalhães C de C et al. Bioactive compounds and antioxidant activity of fresh exotic fruits from northeastern Brazil. Food Res Int 2011; 44:2155–2159 [View Article]
    [Google Scholar]
  44. Ceva-Antunes PMN, Bizzo HR, Silva AS, Carvalho CPS, Antunes OAC. Analysis of volatile composition of siriguela (Spondias purpurea L.) by solid phase microextraction (SPME). LWT - Food Sci Tech 2006; 39:437–443 [View Article]
    [Google Scholar]
  45. Engels C, Gräter D, Esquivel P, Jiménez VM, Gänzle MG et al. Characterization of phenolic compounds in jocote (Spondias purpurea L.) peels by ultra high-performance liquid chromatography/electrospray ionization mass spectrometry. Food Res Int 2012; 46:557–562 [View Article]
    [Google Scholar]
  46. Clinical Laboratory Standards Institute Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard M7-A11 Wayne, PA, USA: CLSI; 2018
    [Google Scholar]
  47. Clinical Laboratory Standards Institute Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, Approved Standard M27, 4th edn. edn Wayne, PA, USA: CLSI; 2017
    [Google Scholar]
  48. Clinical Laboratory Standards Institute Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi, Approved Standard M38, 3rd edn. edn Wayne, PA, USA: CLSI; 2017
    [Google Scholar]
  49. Scherer R, Godoy HT. Antioxidant activity index (AAI) by the 2,2-diphenyl-1-picrylhydrazyl method. Food Chem 2009; 112:654–658 [View Article]
    [Google Scholar]
  50. Snyder LR, Dolan JW. Initial experiments in high-performance liquid chromatographic method development I. use of a starting gradient run. J Chromatogr A 1996; 721:3–14 [View Article]
    [Google Scholar]
  51. Ohno Y, Miyajima A, Sunouchi M. Alternative methods for mechanistic studies in toxicology. Toxicol Lett 1998; 102–103:569–573 [View Article] [PubMed]
    [Google Scholar]
  52. O’Brien J, Wilson I, Orton T, Pognan F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 2000; 267:5421–5426 [View Article] [PubMed]
    [Google Scholar]
  53. Jeong SJ, Huh JI, Shin HK. Cytotoxicity and sub-acute toxicity in Crl:CD (SD) rats of traditional herbal formula Ojeok-san. BMC Complement Altern Med 2015; 15:38 [View Article] [PubMed]
    [Google Scholar]
  54. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990; 82:1107–1112 [View Article] [PubMed]
    [Google Scholar]
  55. Napolitano DR, Mineo JR, de Souza MA, de Paula JE, Espindola LS et al. Down-modulation of nitric oxide production in murine macrophages treated with crude plant extracts from the Brazilian Cerrado. J Ethnopharmacol 2005; 99:37–41 [View Article] [PubMed]
    [Google Scholar]
  56. Niles AL, Moravec RA, Riss TL. In vitro viability and cytotoxicity testing and same-well multi-parametric combinations for high throughput screening. Curr Chem Genomics 2009; 3:33–41 [View Article]
    [Google Scholar]
  57. Rezk A, Al-Hashimi A, John W, Schepker H, Ullrich MS et al. Assessment of cytotoxicity exerted by leaf extracts from plants of the genus Rhododendron towards epidermal keratinocytes and intestine epithelial cells. BMC Complement Altern Med 2015; 15:364 [View Article]
    [Google Scholar]
  58. Onivogui G, Letsididi R, Diaby M, Wang L, Song Y. Influence of extraction solvents on antioxidant and antimicrobial activities of the pulp and seed of Anisophyllea laurina R. Br. ex Sabine fruits. Asian Pac J Trop Biomed 2016; 6:20–25 [View Article]
    [Google Scholar]
  59. Yaneva Z, Simeonov E, Rusenova N, Ivanova D, Nikolova G et al. Flavonoids extraction kinetics, antimicrobial activity and radical scavenging potential of Bulgarian Woundwort (Solidago virgaurea L.). Separations 2022; 9:27 [View Article]
    [Google Scholar]
  60. Queiroz GM, Silva LM, Pietro R, Salgado HRN. Multirresistência microbiana e opções terapêuticas disponíveis. Rev Soc Bras Clin Med 2012; 10:132–138
    [Google Scholar]
  61. Caceres A, Cano O, Samayoa B, Aguilar L. Plants used in Guatemala for the treatment of gastrointestinal disorders. 1. Screening of 84 plants against enterobacteria. J Ethnopharmacol 1990; 30:55–73 [View Article] [PubMed]
    [Google Scholar]
  62. Miranda-Cruz E, EspinosA-Moreno J, Centurion-Hidalgo D, Velazquez-Martinez JR, Alor-Chavez MJ. Actividad antimicrobiana de extractos de Psidium friedrichsthalianum L., Pterocarpus hayesii L., Thynantus guatemalensis L. y Spondias purpurea L. B Latinoam Caribe Pl 2012; 11:354–361
    [Google Scholar]
  63. Garduno Pi C, Barrera Ne LL, Rios Gomez M. Evaluation of the fungicidal activity of leaves powders and extracts of fifteen Mexican plants against Fusarium oxysporum f.sp. gadioli (Massey) Snyder and Hansen. Plant Pathology J 2010; 9:103–111 [View Article]
    [Google Scholar]
  64. Kwolek-Mirek M, Zadrag-Tecza R. Comparison of methods used for assessing the viability and vitality of yeast cells. FEMS Yeast Res 2014; 14:1068–1079 [View Article] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001575
Loading
/content/journal/jmm/10.1099/jmm.0.001575
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error